Cystic Fibrosis News Today Weekly Digest

Cystic Fibrosis Weekly Update Contents: Starting Trikafta with Hope for the CF Community Discovered Bacteria ‘Wars’ May Lead to New Antimicrobial Treatments for CF, Study Suggests Starting Trikafta with Hope for the CF Community Nov 18, 2019 09:00 am | Tré LaRosa I’m writing this column on the day I start treatment with Trikafta (elexacaftor/tezacaftor/ivacaftor), a new cystic fibrosis (CF) medication that I believe will be regarded as an inflection point in CF history. If you’re involved in the CF community or have been on social media in recent weeks, you’re probably aware of Trikafta. The hopes […] The post Starting Trikafta with Hope for the CF Community appeared first on Cystic Fibrosis News Today. Read More Discovered Bacteria ‘Wars’ May Lead to New Antimicrobial Treatments for CF, Study Suggests Nov 18, 2019 07:00 am | Ana Pena, PhD Pseudomonas aeruginosa, a bacteria that commonly causes serious lung infections in people with cystic fibrosis (CF), reacts to other dangerous bacteria in ways that could be exploited to develop new antimicrobial treatments, early research has found. When Staphylococcus aureus is present, P. aeruginosa starts moving faster toward that bacteria, invading and destroying its colonies. These finding […] The post Discovered Bacteria ‘Wars’ May Lead to New Antimicrobial Treatments for CF, Study Suggests appeared first on Cystic Fibrosis News Today. Read More Recent News Patients Adhere Well to CFTR Therapies But High Costs Could Undermine Use, Pharmacy Study Says Vertex Reaches Agreement for CF Medications in Northern Ireland and Wales Rare Disease Film Festival Highlights Patient and Researcher Unity Inspiration for Hire: Sick Candidates Only Proteostasis Therapeutics Completes Enrollment in Phase 2 Study Testing Triple Combination Therapy in Cystic Fibrosis